4.8 Article

Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

Journal

SCIENCE
Volume 345, Issue 6196, Pages 531-531

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1251343

Keywords

-

Funding

  1. Marie Curie Fellowship [328264]
  2. Wellcome Trust [WT100183MA]
  3. Chordoma Foundation
  4. Skeletal Cancer Action Trust
  5. European Molecular Biology Organization [LTF 1203-2012, 1287-2012]
  6. CRUK Clinician Scientist fellowship
  7. National Institute for Health Research
  8. University College London Hospitals Biomedical Research Centre
  9. Cancer Research UK University College London Experimental Cancer Centre
  10. Brussels Region-Impulse Programme Life Sciences
  11. European Union (BASIS)
  12. Wellcome Trust
  13. CRUK [C5047/A14835]
  14. Dallaglio Foundation
  15. Bob Champion Trust
  16. Orchid Cancer appeal
  17. RoseTrees Trust
  18. North West Cancer Research Fund, Big C
  19. Grand Charity of Freemasons
  20. Research Foundation Flanders (FWO)
  21. 14M Genomics Limited
  22. BBSRC [BBS/E/F/00042686, BBS/E/F/00044431] Funding Source: UKRI
  23. MRC [G0900871] Funding Source: UKRI
  24. Biotechnology and Biological Sciences Research Council [BBS/E/F/00042686, BBS/E/F/00044431] Funding Source: researchfish
  25. Cancer Research UK [16942, 15007, 14835, 19556, 17528] Funding Source: researchfish
  26. Medical Research Council [G0900871] Funding Source: researchfish
  27. National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish
  28. Rosetrees Trust [M35-F1-CD1] Funding Source: researchfish

Ask authors/readers for more resources

Long interspersed nuclear element-1 (L1) retrotransposons are mobile repetitive elements that are abundant in the human genome. L1 elements propagate through RNA intermediates. In the germ line, neighboring, nonrepetitive sequences are occasionally mobilized by the L1 machinery, a process called 3' transduction. Because 3' transductions are potentially mutagenic, we explored the extent to which they occur somatically during tumorigenesis. Studying cancer genomes from 244 patients, we found that tumors from 53% of the patients had somatic retrotranspositions, of which 24% were 3' transductions. Fingerprinting of donor L1s revealed that a handful of source L1 elements in a tumor can spawn from tens to hundreds of 3' transductions, which can themselves seed further retrotranspositions. The activity of individual L1 elements fluctuated during tumor evolution and correlated with L1 promoter hypomethylation. The 3' transductions disseminated genes, exons, and regulatory elements to new locations, most often to heterochromatic regions of the genome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available